These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13469430)

  • 1. Tebamin: a derivative of p-aminosalicylic acid; blood levels, absorption and excretion following oral administration.
    FREDERIKSEN E; JENSEN KA; MORCH P; TYBRING L
    Acta Pharmacol Toxicol (Copenh); 1957; 14(1):58-66. PubMed ID: 13469430
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on absorption and excretion of para-aminosalicylic acid administered by various routes].
    IZZO RA; MARENZI AD; GOMEZ CJ; ROSS S
    Publ B Aires Cent Investig; 1954-1955; 18():9-17. PubMed ID: 13336211
    [No Abstract]   [Full Text] [Related]  

  • 3. The absorption, distribution, excretion and fate of para-aminosalicylic acid.
    WAY EL; SMITH PK
    J Pharmacol Exp Ther; 1948 Jul; 93(3):368-82. PubMed ID: 18882143
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of p-aminosalicylic acid in body fluids.
    NEWHOUSE JP; KLYNE W
    Biochem J; 1949; 44(2):vii. PubMed ID: 18210434
    [No Abstract]   [Full Text] [Related]  

  • 5. [Absorption, circulation in the blood, distribution in various organs, and excretion of paraaminosalicylic acid].
    KOZLOVSKAIA OI
    Farmakol Toksikol; 1956; 19(2):42-5. PubMed ID: 13318024
    [No Abstract]   [Full Text] [Related]  

  • 6. [Formation and excretion of RHO-aminosalicylic acid metabolites].
    LAUENER H; HODLER J; FAVEZ G; DETTWILER E; HADORN L
    Klin Wochenschr; 1957 Apr; 35(8):393-401. PubMed ID: 13450229
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiments on the absorption of p-aminosalicylic hydrazide; blood levels in man after oral and rectal administration].
    RAVAZZONI C; CAVALLERI L; CHIARLO B
    Arch Maragliano Patol Clin; 1955 Jun; 10(3):809-12. PubMed ID: 13269225
    [No Abstract]   [Full Text] [Related]  

  • 8. [The action of ethamide on the excretion of p-aminosalicylic acid by the kidneys].
    SNEGIREV EA
    Probl Tuberk; 1962; 40(4)():87-92. PubMed ID: 13914568
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective inhibition of vitamin B 12 absorption by para-aminosalicylic acid.
    Toskes PP; Deren JJ
    Gastroenterology; 1972 Jun; 62(6):1232-7. PubMed ID: 5050320
    [No Abstract]   [Full Text] [Related]  

  • 10. [Formation of metabolites of benzoyl-para-amino-salicylic acid (C-14-B-PAS) in the rat liver and its excretion in the urine and bile].
    JEUNET F; LAUBER E; AEBI H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1962; 242():564-75. PubMed ID: 14451756
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of p-aminosalicylic acid levels in the blood and its urinary excretion].
    CASTILHO Vde P
    Rev Quim Farm; 1951 Oct; 16(10):271-9. PubMed ID: 14930444
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers.
    Sandborn WJ; Hanauer SB; Buch A
    Aliment Pharmacol Ther; 2004 May; 19(10):1089-98. PubMed ID: 15142198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Techniques of chromatography and determination of para-aminosalicylic acid and its derivatives in biological fluids].
    GUILLAUME J; PETIT H
    Ann Inst Pasteur Lille; 1958-1959; 10():73-88. PubMed ID: 13963408
    [No Abstract]   [Full Text] [Related]  

  • 14. Toleration and absorption of sodium para-aminosalicylate and para-aminosalicylic acid (neopasalate). Comparison with other forms of para-aminosalicylic acid.
    Yue WY; Cohen SS
    Dis Chest; 1966 Feb; 49(2):165-74. PubMed ID: 5907972
    [No Abstract]   [Full Text] [Related]  

  • 15. [Resorption and excretion of PAS, with a contribution on quantitative analysis].
    SCHMITZ A; WAWER J
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1951; 105(2):178-83. PubMed ID: 14830568
    [No Abstract]   [Full Text] [Related]  

  • 16. [COMPARATIVE STUDY OF PAS LEVELS IN BLOOD AND URINE].
    GAJEWSKA E
    Gruzlica (1926); 1964 Nov; 32():1031-4. PubMed ID: 14327143
    [No Abstract]   [Full Text] [Related]  

  • 17. [CONCENTRATION OF NA-PAS IN THE BLOOD AND ITS TOLERANCE FOLLOWING SINGLE ORAL ADMINISTRATION OF THE WHOLE DAILY DOSE].
    WARESKA W; IZDEBSKA-MAKOSA Z
    Gruzlica (1926); 1964 Apr; 32():305-9. PubMed ID: 14183277
    [No Abstract]   [Full Text] [Related]  

  • 18. [Behavior of blood concentration and elimination in the urine of p-aminosalicylic acid after administration of substances with retarding action; experimental and clinical research].
    BERTOLANI F
    Rass Fisiopatol Clin Ter; 1950; 22(1-2):41-62. PubMed ID: 15441150
    [No Abstract]   [Full Text] [Related]  

  • 19. Absorption and excretion of sulfathiadiazole and sulfamethylthiadiazole after oral administration in human beings.
    MEADS M; FINLAND M
    J Lab Clin Med; 1946 Aug; 31():900-9. PubMed ID: 20995239
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum para-aminosalicylic acid following oral ingestion in children.
    SODERHJELM L
    Tex Rep Biol Med; 1949; 7(3):471-9. PubMed ID: 18143811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.